K
Kunihiko Tsuji
Publications - 134
Citations - 4971
Kunihiko Tsuji is an academic researcher. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 23, co-authored 94 publications receiving 1790 citations.
Papers
More filters
Journal ArticleDOI
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications
Atsushi Hiraoka,Takashi Kumada,Masatoshi Kudo,Masashi Hirooka,Kunihiko Tsuji,Ei Itobayashi,Kazuya Kariyama,Toru Ishikawa,Kazuto Tajiri,Hironori Ochi,Toshifumi Tada,Hidenori Toyoda,Kazuhiro Nouso,Kouji Joko,Hideki Kawasaki,Yoichi Hiasa,Kojiro Michitaka +16 more
TL;DR: ALBI grade is a useful and easy classification system for assessment of hepatic function for therapeutic decision making and prognosis based on ALBI grade/ALBI-T score was better than that based on liver damage/modified JIS score and Child-Pugh/JIS score.
Journal ArticleDOI
A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.
Keiji Matsubayashi,Jong-Hon Kang,Hidekatsu Sakata,Kazuaki Takahashi,Motohiro Shindo,Masaru Kato,Shinichiro Sato,Toshiaki Kato,Hiroyuki Nishimori,Kunihiko Tsuji,Hiroyuki Maguchi,Junichi Yoshida,Hiroshi Maekubo,Shunji Mishiro,Hisami Ikeda +14 more
TL;DR: Five cases of transfusion transmission of hepatitis’E virus (HEV) have been reported so far, but the infection routes of the causative donors remain unclear and the progress of virus markers in the entire course of HEV infection has not been well documented.
Journal ArticleDOI
Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes
TL;DR: NAFLD improvement is associated with T2DM incidence reduction and this work concluded that type 2 diabetes mellitus patients with a history of nonalcoholic fatty liver disease should consider undergoing a second health check twice in order to be eligible for treatment with NAFLD.
Journal ArticleDOI
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.
Atsushi Hiraoka,Takashi Kumada,Masanori Atsukawa,Masashi Hirooka,Kunihiko Tsuji,Toru Ishikawa,Koichi Takaguchi,Kazuya Kariyama,Ei Itobayashi,Kazuto Tajiri,Noritomo Shimada,Hiroshi Shibata,Hironori Ochi,Toshifumi Tada,Hidenori Toyoda,Kazuhiro Nouso,Akemi Tsutsui,Takuya Nagano,Norio Itokawa,Korenobu Hayama,Michitaka Imai,Kouji Joko,Yohei Koizumi,Yoichi Hiasa,Kojiro Michitaka,Masatoshi Kudo +25 more
TL;DR: Appropriate factors indicating newly developed lenvatinib treatment for unresectable hepatocellular carcinoma (u‐HCC) by investigating real‐world clinical features of patients are assessed.
Journal ArticleDOI
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
Atsushi Hiraoka,Takashi Kumada,Kunihiko Tsuji,Koichi Takaguchi,Ei Itobayashi,Kazuya Kariyama,Hironori Ochi,Kazuto Tajiri,Masashi Hirooka,Noritomo Shimada,Toru Ishikawa,Yoshihiko Tachi,Toshifumi Tada,Hidenori Toyoda,Kazuhiro Nouso,Kouji Joko,Yoichi Hiasa,Kojiro Michitaka,Masatoshi Kudo +18 more
TL;DR: The detailed stratification ability of mALBI grade for hepatic reserve function is suitable for the recent trend of HCC patients, whilemALBI-T may provide a more accurate predictive value than existing total staging scoring systems.